Active Ingredient: AMIKACIN SULFATE
Proprietary Name: AMIKACIN SULFATE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 50MG BASE/ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A063274
Product Number: 001
Approval Date: May 18, 1992
Applicant Holder Full Name: HIKMA PHARMACEUTICALS USA INC
Marketing Status:
Discontinued
Patent and Exclusivity Information